The effect of L-2-amino-4-methoxy-trans-3-butenoic acid on serine hydroxymethyl transferase.
The tumour growth inhibitor L-2-amino-4-methoxy-trans-3-butenoic acid (Ro07-7957) inhibits serine hydroxymethyltransferase in cytosolic extracts of Walker carcinoma non-competitively with respect to L-serine with an apparent inhibition constant similar to the Km-value for L-serine. The kinetics of inactivation suggest that it reacts as an irreversible substrate analogue. Incubation of Walker cells with Ro07-7957 causes an increase in serine hydroxymethyltransferase activity which is most pronounced at concentrations less than or equal to LD50. This increase in enzyme activity does not occur in the presence of cycloheximide. These results suggest that inhibition of serine hydroxymethyltransferase in intact cells is accompanied by an increase in enzyme biosynthesis and that the growth inhibitory property or Ro07-7957 does not involve interference with the conversion of serine to glycine.
D000613:Aminobutyrates / Q000494:pharmacology*; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology*; D002279:Carcinoma 256, Walker / Q000201:enzymology; D003513:Cycloheximide / Q000494:pharmacology; D005347:Fibroblasts / Q000201:enzymology; D012696:Glycine Hydroxymethyltransferase / Q000037:antagonists & inhibitors*; D006801:Humans; D066298:In Vitro Techniques; D011732:Pyridoxal Phosphate / Q000494:pharmacology; D051381:Rats; D014166:Transferases / Q000037:antagonists & inhibitors*
D000613:Aminobutyrates; D000903:Antibiotics, Antineoplastic; C000264:2-amino-4-methoxy-3-butenoic acid; D011732:Pyridoxal Phosphate; D003513:Cycloheximide; D014166:Transferases; D012696:Glycine Hydroxymethyltransferase